Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ICON
CRO
CROs should brace for continued slow Big Pharma demand: analyst
While large pharma spending on R&D increased by 9.7% in 2024, it's expected to increase by only 2.2% this year for 13 Big Pharmas.
Darren Incorvaia
Jan 28, 2025 3:45pm
Irish CRO giant Icon plots layoffs after underwhelming Q3
Oct 25, 2024 1:19pm
Icon, Saphetor partner on trials targeting precision medicine
Oct 18, 2023 7:05am
Icon to conduct government trial of next-gen COVID-19 vaccines
Sep 13, 2023 10:27am
Virtual clinical trials market worth $8B as CROs add products
Mar 21, 2022 4:20pm
Decentralized trials, broader services key trends for CROs
Jan 14, 2022 10:25am
